- Company Directors - C
- Cartwright Gene S
Insider Trading History of Cartwright Gene S
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Cartwright Gene S since 2014.
The trader's CIK number is 1580020.
At the time of the last reporting, Cartwright Gene S was the Director of Spectrx Inc. (stock ticker symbol SPRX).
Also see all insider trading activities at Spectrx Inc.
Note that in the past
Cartwright Gene S also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Spectrx Inc (GTHP) by Cartwright Gene S
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2015 | GTHP | 37,504 | $4,500 | 0 | $0 | 0 | $0 |
2014 | GTHP | 100,000 | $48,556 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Nanosphere Inc (NSPH) by Cartwright Gene S
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2014 | NSPH | 23,200 | $49,160 | 0 | $0 | 0 | $0 |
Insider trading activities at 2 companies by Cartwright Gene S:
1. Spectrx Inc (GTHP)
2. Nanosphere Inc (NSPH)
Table 1. Insider trading of Spectrx Inc (GTHP) by Cartwright Gene S
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2015-06-29 | GTHP | Buy | 37,504 | .12 | 4,500 |
2014-06-19 | GTHP | Buy | 23,000 | .48 | 11,086 |
2014-06-20 | GTHP | Buy | 27,000 | .49 | 13,122 |
2014-06-18 | GTHP | Buy | 26,000 | .49 | 12,636 |
2014-06-17 | GTHP | Buy | 24,000 | .49 | 11,712 |
Table 2. Insider trading of Nanosphere Inc (NSPH) by Cartwright Gene S
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2014-03-26 | NSPH | Buy | 23,200 | 2.12 | 49,160 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Cartwright Gene S
(Director of Spectrx Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.